While most studies suggest that lung adenocarcinomas with TP53 mutations carry a worse prognosis and are more resistant to chemotherapy and radiation,3, 10, 20, 21, 22, 23 others have reported equivocal prognostic value with respect to TP53 mutation status.11, 19, 24. This evidence concerns the gene TP53 and lung adenocarcinoma.